$PTGEF (Portage Biotech Inc. $0.13) Never been hyped never been followed. One seeking alpha article by Biotech Research Group. Portage has assembled the best scientific team and has 3 drugs ready for phase 3 clinical trials. CNS indications...anxiety ALS etc... Lots in the pipeline....Biggest holding: Majority stake in Biohaven Pharmaceuticals. Collaborations with Yale and Rutgers. Insiders own 55 percent of the 250 Million outstanding. Lots of DD available. Should have lots of news prior to year end and catch the street's eye.